INHIBITION OF FORMYLGLYCINAMIDE RIBONUCLEOTIDE SYNTHESIS IN NEOPLASTIC CELLS BY PURINES AND ANALOGS.
D000225:Adenine; D000818:Animals; D000963:Antimetabolites; D000970:Antineoplastic Agents; D001377:Azaserine; D002294:Carcinoma, Squamous Cell; D005998:Glycine / Q000031:analogs & derivatives; D007042:Hypoxanthines; D007093:Imidazoles; D007939:Leukemia L1210; D015122:Mercaptopurine; D009711:Nucleotides; D010600:Pharmacology; D011687:Purines; D012106:Research; D012265:Ribonucleotides; D013866:Thioguanine; D046509:Tissue Culture Techniques; D014970:Xanthines
D000963:Antimetabolites; D000970:Antineoplastic Agents; D007042:Hypoxanthines; D007093:Imidazoles; C407066:N-formylglycinamide; D009711:Nucleotides; D011687:Purines; D012265:Ribonucleotides; D014970:Xanthines; C002824:phosphoribosyl-N-formylglycineamide; D001377:Azaserine; D015122:Mercaptopurine; D013866:Thioguanine; D000225:Adenine; D005998:Glycine; C030985:purine
ADENINE; ANTIMETABOLITES; ANTINEOPLASTIC AGENTS; AZASERINE; CARCINOMA, EPIDERMOID; EXPERIMENTAL LAB STUDY; GLYCINE; HYPOXANTHINES; IMIDAZOLES; LEUKEMIA L1210; MERCAPTOPURINE; NUCLEOTIDES; PHARMACOLOGY; THIOGUANINE; TISSUE CULTURE; XANTHINES